Asker, Norway, 1 January 2026

Cambi and NCC have entered into a Letter of Intent (LOI) for a medium
construction contract to deliver its robust thermal hydrolysis process (THP)
technology to modernise wastewater solids handling at the Malad wastewater
treatment plant in Mumbai, India. NCC, a large and experienced Indian
construction and infrastructure enterprise, will build the project for the
Brihanmumbai Municipal Corporation (BMC). A definitive agreement is expected to
follow completion of early design and final commercial negotiations.

Thermal hydrolysis will enhance the processing of the biological sludge at the
site, breaking down its cellular structure and making it easier and faster to
process in the subsequent anaerobic digestion step. Cambi's solution will
increase biogas production with the equivalent electricity demand of more than
5,100 Indian homes. The resulting low-odour biosolids product will contain less
water and be easier to transport away, reducing daily traffic by 10 truckloads.
It can replace synthetic fertilisers when used on land, reducing fossil fuel
consumption further.

"Cambi is deeply committed to assisting the municipality of Mumbai on its
journey to modern, efficient biosolids handling and improved sanitation. Our
collaboration with NCC in the Malad wastewater treatment plant, one of the
city's largest, marks an important second step towards transforming wastewater
in Mumbai to clean water and safe biosolids. By integrating our THP technology,
the plant will exceed current environmental standards while achieving
substantial cost savings over traditional methods. We look forward to working
together on this important project for Mumbai", commented Per Lillebø, CEO at
Cambi.

Malad is one of the seven new wastewater treatment plants built by BMC to
improve sanitation in the greater Mumbai area, servicing the city's western
neighbourhoods. On average, it is designed to receive the equivalent of an
Olympic swimming pool of wastewater every eight minutes. The new plant will
utilise efficient technologies to enhance the local environment and deliver
cost-effective sanitation services, as well as maximising the reuse of the
treated wastewater and sludge.

Malad will be Cambi's second THP project in Mumbai and India. Signing of the
contract is expected following final commercial negotiations and completion of
early design activities, with delivery of the THP systems to the site scheduled
for 2027.

For more information, please contact: 
o	Per Lillebø, CEO, per.lilleboe@cambi.com, +47 918 88 365
o	Per Olav Collin, Acting CFO, per.olav.collin@cambi.com, +47 986 48 572
o	Dr PKC Bose, Chairman of Cambi India Pvt Ltd and Executive Advisor to the
Board of Directors in Cambi ASA, pkc.bose@cambi.com, +91 989 000 6968

 
Note on contract value:
Category 	Medium
	        100-200	

About Cambi
Cambi is a global biogas technology and solutions supplier for wastewater
treatment plants and anaerobic digestion facilities. Since 1992, Cambi has
retained market leadership through continuous innovation and a robust portfolio
of proven and patented technologies. With strong project delivery and customer
support capabilities, the company has delivered many well-performing
installations in 28 countries on six continents.
Cambi's thermal hydrolysis process increases renewable energy output, reduces
operational costs, and minimises greenhouse gas emissions. It is suitable for
both new and existing anaerobic digestion sites and compatible with all
biosolids outlets, including land application and thermal processes such as
drying, pyrolysis, and incineration. Thermal hydrolysis is robust to regulatory
changes, meeting all sludge and waste treatment legal requirements.
Cambi is listed on Euronext Growth Oslo, a multilateral trading facility in
Euronext, Europe's largest stock exchange platform. Find out more at cambi.com.